{{Rsnum
|rsid=11599315
|Gene=ADARB2
|Chromosome=10
|position=1343017
|Orientation=plus
|GMAF=0.343
|Gene_s=ADARB2
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 13.3 | 49.6 | 37.2
| HCB | 0.7 | 12.4 | 86.9
| JPT | 3.5 | 18.6 | 77.9
| YRI | 42.1 | 44.1 | 13.8
| ASW | 46.4 | 48.2 | 5.4
| CHB | 0.7 | 12.4 | 86.9
| CHD | 0.0 | 8.3 | 91.7
| GIH | 3.0 | 35.6 | 61.4
| LWK | 48.6 | 44.0 | 7.3
| MEX | 7.0 | 22.8 | 70.2
| MKK | 39.5 | 41.4 | 19.1
| TSI | 10.8 | 46.1 | 43.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=T
  |Pval=5E-6
  |OR=3.88
  |ORtxt=[2.21-5.55] mg/dL decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}